Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial - Winston, D J; Saliba, F; Blumberg, E (Am J Transplant, 2012)
, et al; 1263-301 Clinical Study Group.